In a typical PBMC freezing protocol, PBMCs are cryopreserved in a PBMC freezing media that protects them from ice crystal injury during both freezing and thawing. A standard PBMC cryopreservation protocol often uses either 90% fetal bovine serum (FBS) with 10% dimethyl sulfoxide (DMSO), or 70% complete PBMC medium supplemented with 20% FBS and 10% DMSO as the PBMC freezing media. During freezing PBMC, cells are cooled at a controlled rate of about 1 degree Celsius per minute and then transferred to liquid nitrogen for long-term PBMC storage as frozen PBMC stocks. When the PBMC cryopreservation vials are needed, they are rapidly thawed in a 37 degree Celsius water bath, and the DMSO-containing medium is diluted and removed promptly to minimize toxicity and support recovery before returning the cells to an appropriate PBMC culture medium.
In most PBMC culture protocol documents, RPMI 164 is considered the standard basal PBMC medium for PBMC isolation and routine culture. DMEM contains higher levels of several amino acids and vitamins compared with RPMI 164, so many PBMC cell culture protocol designs use DMEM when a richer PBMC culture media is needed or when specific experimental requirements call for it. Iscove’s Modified Dulbecco’s Medium (IMDM), derived from DMEM, is frequently chosen in PBMC isolation and culture protocol workflows that focus on T cell assays and functional studies, because this PBMC culture medium formulation supports strong lymphocyte proliferation and activity.
CellStore PBMC Cryopreservation Medium (CS-PM-D1) is a specialized freezing solution designed for long-term cryopreservation of peripheral blood (PB) and cord blood (CB)–derived mononuclear cells and buffy coats. Its optimized formulation provides effective protection against ice crystal damage in standard PBMC cryopreservation protocols, helping to maintain high cell viability and functional performance after thawing. Residual red blood cells present during PBMC isolation have minimal impact on the success of PBMC freezing, as red cells lack appropriate cryoprotectants and tend to lyse at low temperatures in typical cell freezing media, thus not significantly interfering with PBMC preservation. CellStore supports this product with a dedicated PBMC Cryopreservation Medium Protocol and guidance for PBMC culture media use, enabling users to plan freezing strategies according to initial PBMC counts and to perform reliable post-thaw culture and functional assays.
PBMCs are most commonly isolated from fresh whole blood or leukocyte-rich preparations using density gradient methods or direct immunomagnetic kits as part of a standard PBMC isolation and culture protocol. However, in practice it is more typical to first isolate PBMCs from fresh blood, then follow a validated PBMC cryopreservation protocol to generate frozen PBMC stocks that can later be thawed and used for downstream applications. After PBMC freezing and storage, these frozen PBMC samples can be recovered and subjected to further subset isolation with immunomagnetic systems, allowing batching of blood collections and more flexible experimental scheduling while preserving acceptable cell yield and viability.
To prepare a standard PBMC freezing media for PBMCs or other mammalian cells, you can follow a basic PBMC freezing protocol that uses either 90% heat-inactivated FBS with 10% DMSO or 70% complete PBMC media, 20% FBS, and 10% DMSO. The components of the PBMC media should be filter-sterilized under aseptic conditions, and the freezing medium should be pre-cooled to about 4 degrees Celsius before mixing with the cell pellet. For a typical PBMC cryopreservation protocol, the cells are gently resuspended in the cold freezing medium at a target density such as 1–10 × 10⁶ cells per milliliter, dispensed into cryovials, and then processed using a controlled-rate freezer or an isopropanol freezing container to ensure gradual freezing PBMC before transfer to liquid nitrogen for long-term PBMC storage.
